INS and Hyperglycemia: While recognizing the significance and health advantages of enhanced insulin sensitivity, our primary focus was on mitigating postprandial hyperglycemia (defined as a primary outcome) due to its direct correlation with acute changes in biomarkers of cardiovascular disease (CVD) risk.